Novavax Inc., of Gaithersburg, Md., has secured a $1.6 billion federal grant to develop, assess and construct a coronavirus vaccine, the company announced.
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.